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Background: Since adequate sleep is essential for optimal inpatient rehabilitation, there is an increased interest in sleep
assessment. Unobtrusive, contactless, portable bed sensors show great potential for objective sleep analysis.
Objective: The aim of this study was to investigate the feasibility of a bed sensor for continuous sleep monitoring overnight in
a clinical rehabilitation center.
Methods: Patients with incomplete spinal cord injury (iSCI) or stroke were monitored overnight for a 1-week period during
their in-hospital rehabilitation using the Emfit QS bed sensor. Feasibility was examined based on missing measurement nights,
coverage percentages, and missing periods of heart rate (HR) and respiratory rate (RR). Furthermore, descriptive data of sleep-related
parameters (nocturnal HR, RR, movement activity, and bed exits) were reported.
Results: In total, 24 participants (12 iSCI, 12 stroke) were measured. Of the 132 nights, 5 (3.8%) missed sensor data due to
Wi-Fi (2), slipping away (1), or unknown (2) errors. Coverage percentages of HR and RR were 97% and 93% for iSCI and 99%
and 97% for stroke participants. Two-thirds of the missing HR and RR periods had a short duration of ≤120 seconds. Patients
with an iSCI had an average nocturnal HR of 72 (SD 13) beats per minute (bpm), RR of 16 (SD 3) cycles per minute (cpm), and
movement activity of 239 (SD 116) activity points, and had 86 reported and 84 recorded bed exits. Patients with a stroke had an
average nocturnal HR of 61 (SD 8) bpm, RR of 15 (SD 1) cpm, and movement activity of 136 (SD 49) activity points, and 42
reported and 57 recorded bed exits. Patients with an iSCI had significantly higher nocturnal HR (t18=−2.1, P=.04) and movement
activity (t18=−1.2, P=.02) compared to stroke patients. Furthermore, there was a difference between self-reported and recorded
bed exits per night in 26% and 38% of the nights for iSCI and stroke patients, respectively.
Conclusions: It is feasible to implement the bed sensor for continuous sleep monitoring in the clinical rehabilitation setting.
This study provides a good foundation for further bed sensor development addressing sleep types and sleep disorders to optimize
care for rehabilitants.
(JMIR Mhealth Uhealth 2021;9(2):e24339) doi: 10.2196/24339
KEYWORDS
continuous sleep monitoring device; bed sensor technology; mHealth; nocturnal heart rate; nocturnal respiratory rate; nocturnal
movement activity; neurological disorders; incomplete spinal cord injury; stroke; inpatient rehabilitation; clinical application
JMIR Mhealth Uhealth 2021 | vol. 9 | iss. 2 | e24339 | p. 1http://mhealth.jmir.org/2021/2/e24339/
(page number not for citation purposes)




An important aim of rehabilitation therapy for patients with
neurological disorders such as stroke or spinal cord injury (SCI;
including incomplete SCI [iSCI]) is to develop skills needed
for independent living. Although rehabilitation focuses mainly
on activities during the day, sleep is also important for
rehabilitation. Patients with a stroke or SCI can face sleep
disturbances including sleep disorders [1-3]. Up to 60% of
patients with stroke or SCI suffer from sleep disorders [1,2],
which is high compared to the 24% of people with sleep
problems in the general European population [4]. Those sleep
disturbances may interfere with their long-term rehabilitation
process for a variety of reasons in terms of lowering motivation,
energy, and concentration, which are needed to fully participate
in the rehabilitation process [3,5]. Sufficient and adequate sleep
promotes rehabilitation by gaining physical and psychological
energy [3,6]. It also improves implicit learning of motor skills
[7] and cognitive performance [8-10], which may result in
performance improvements [11]. Furthermore, sleep positively
affects patients’ daily activity and reduces the risk of diabetes,
cardiovascular diseases, and development of metabolic disorders
[1,2,8,10,12,13], which in its totality contributes to the quality
of life. Hence, sleep is essential for optimal inpatient
rehabilitation and long-term health, indicating the importance
of sleep assessment.
At the moment, polysomnography (PSG) is considered one of
the most comprehensive methods for sleep assessment and
therefore the gold standard for the diagnosis of many sleep
disorders [14,15]. Unfortunately, PSG is generally experienced
as impractical, expensive, and limited in accessibility during
inpatient rehabilitation in specialized rehabilitation centers
[3,14,16-18]. Subjective measurements, such as self-report
questionnaires, are inexpensive and easy to implement [16].
However, they summarize only the perception of the patient
and are prone to missing data [19,20]. Therefore, a wide range
of sleep technology devices used to assess sleep have been
developed [18,21,22]. The main aim of those devices is to be
less expensive, less invasive, and more accessible for assessing
sleep compared to PSG. These sleep technology devices can be
classified into contact (actigraphy, electroencephalography) and
contactless (ballistocardiography [BCG], microphone, infrared,
video camera, echo-based, or mobile) devices [19,22]. The
accuracy and reliability of these devices have been continuously
increased with the advances of technology [19]; however, most
of them have several disadvantages when applied in a clinical
inpatient rehabilitation setting. Disadvantages of contact devices
comprise discomfort and disruption of sleep, potential for
misplacement, and limited data storage and battery capacity
[17,18,22]. Contactless portable devices based on infrared, video
camera, echo, or mobile phones have the disadvantages that
they might lead to incorrect measurements when there are
multiple patients in one room, patients change rooms, or nursing
staff visits the patient during the night [17,18,22]. Furthermore,
most do not monitor heart rate (HR) and respiratory rate (RR),
two vital signs during inpatient rehabilitation [23]. A solution
to overcome the aforementioned disadvantages of various sleep
measuring methods can possibly be found in the recent
development of unobtrusive, contactless, portable sensor–based
devices for objective sleep analysis based on BCG. BCG
technology consists of a highly sensitive pressure sensor, which
can measure HR, RR, and movement activity (body movements),
which are parameters used in sleep monitoring [24,25]. Studies
have reported nocturnal HR and RR coverage ranging between
83% and 92% [26,27]. In this way, a portable bed sensor based
on BCG can measure multiple nights without causing any
discomfort over a longer period of time. Furthermore, this bed
sensor is not prone to disturbance of its signal by others in
comparison to the other contactless devices. Therefore, the
portable bed sensor based on BCG has potential to be suitable
for sleep monitoring in long stay rehabilitation inpatients such
as stroke or SCI [28-30].
To our knowledge, portable bed sensors have not yet been
implemented during inpatient rehabilitation, although they could
be useful in clinical practice. Only a few studies have included
a small number of patients using portable bed sensors under
research circumstances in a hospital setting [31-33]. However,
human, technological, or environmental issues might come
along with implementation of sensors in noncontrolled settings
[34-36]. Therefore, the aim of this study was to investigate the
feasibility of an unobtrusive, contactless, portable bed sensor
for continuous sleep monitoring overnight in a clinical
rehabilitation SCI and stroke ward. Feasibility was examined
based on missing measurement nights. To examine the ability
of the bed sensor to capture sleep-related parameters, the
following secondary outcomes were analyzed: coverage
percentages of HR and RR, missing HR and RR periods,
interruptions of HR and RR signals due to bed exits, and the
discrepancy in number of reported and recorded bed exits.
Additionally, descriptive data on average nocturnal HR, RR,
and movement activity for iSCI and stroke patients were
reported. We hypothesized that the bed sensor is feasible in
inpatient rehabilitation and is considered feasible if at least 95%
of the nights were captured and the total coverage of nocturnal
HR and RR was above 80% [26,27,36]. Based on the literature,
a higher nocturnal HR for iSCI compared to stroke patients was
hypothesized [37,38], which serves as a first indication of group
validity of the bed sensor.
Methods
Study Design
This observational cohort study was carried out at the Sint
Maartenskliniek (Ubbergen, the Netherlands). This study was
part of an overarching study [39], which aimed to develop a
sensor-based technological platform to monitor gait and sleep.
It was performed in the clinical treatment environment of the
rehabilitation department to integrate the intervention in a
realistic setting. Interaction between participant and researcher
was kept to a minimum to prevent interference with clinical
practice. The study was conducted in accordance with the
principles of the Declaration of Helsinki (64th World Medical
Association General Assembly, Fortaleza, Brazil, October 2013)
and approved by the Medical Ethical Research Committee of
Arnhem-Nijmegen (4222-2018).
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Twelve iSCI patients (ASIA [American Spinal Injury
Association] scale C/D) and 12 first-ever stroke survivors
(Functional Ambulation Category score≥2) were recruited (both
sexes, age≥16 years), as they both have relatively long inpatient
hospital stay durations. The following criteria had been applied
in relation to the overarching project: minimum age of 16 years,
not wheelchair-bound, participation in ambulation therapy, no
other comorbidities affecting patients’ ambulatory function,
and no use of an anti-decubitus air bed mattress because of
interference with the measurement. Participants who were
unable to grant permission to participate in the study due to
language issues or cognitive impairment were excluded.
Patients who were already admitted to the inpatient clinical
rehabilitation ward of the Sint Maartenskliniek were
pre-assessed for eligibility for study participation. The Montreal
Cognitive Assessment test score, which was already performed
by the responsible rehabilitation physician for usual care, was
used to determine if the patient was capable of participating in
the study. Eligible patients were asked to voluntarily participate
in the study, and participation was not incentivized. After
patients were asked to participate, they had time to consider
participation before deciding whether or not to participate in
the study. There was no intrusion on the patient’s rehabilitation
process, and patients could follow their normal care program
based on their personal needs. Patients were hospitalized for
both day and night during weekdays (sometimes during
weekends) for several weeks. Written informed consent was
obtained from all participants before the start of the
measurements.
Instrumentation
A portable bed sensor, the Emfit QS sleep tracker (Emfit Ltd;
542 mm × 70 mm × 1.4 mm), was used. The sensor consists of
thin elastic lightweight polymer layers separated by air voids
and coated with electrically conductive, permanently polarized
layers. The Emfit bed sensor was placed under the bed mattress
at the thoracic area of the sleeping patient [40]. Changes in
pressure distribution generate a charge on the electrically
conductive surfaces of the sensor, which can be measured as a
current or a voltage signal [32]. The sensor was compatible with
IEEE 802.11b/g/n networks, an international standard local area
network protocol, and provides data about HR, RR, and
movement activity every 4 seconds. Movement activity was
expressed by activity points (AP) in which a higher number of
AP corresponds with larger body movements. Small movements
with the arm will result in fewer AP compared to whole body
movements if sleep position changes. Bed exits were identified
by the sensor if no pressure was detected. Bed exits were
described by duration and frequency. The Emfit bed sensor
needs at least one hour of recording before generating a data
file. Data were sent to the Emfit server [41].
The Emfit bed sensor was designed for people who lie in bed
with the intention to sleep. As the Emfit bed sensor has not been
validated to indicate the moment of sleep onset and offset in
iSCI and stroke patients, a sleep questionnaire was filled out
manually by the patient himself or herself (or with help of the
nursing staff) at the end of every night regarding bedtime, time
of awakening, bed exits, and use of sleep medication. Those
questions were based on the Pittsburgh Sleep Quality Index
referring to “last night” instead of “the last month” [42].
Procedure
After written informed consent, the bed sensor was placed under
the bed mattress of the participant by the researcher, and the
sleep questionnaires were handed over to the participant. The
bed sensor remained under the bed mattress for 1 week. During
the weekend, most patients were allowed to stay at home for
one or two nights for rehabilitation purposes. If a participant
was transferred to a different room, the nurse was responsible
for moving the bed sensor. If there were any errors or questions
regarding the bed sensor during the measurement week, the
researcher visited the patient. Visits by the researcher during
the measurement week were considered as interference and
registered. At the end of the measurement week, the researcher
collected the bed sensor and the questionnaires. Only one
researcher (MMSH) was involved in the described procedure
and was not blinded to the study outcomes.
Outcome Measures
The primary outcome for feasibility was the percentage of
missing measurement nights. A night was considered as missing
if data were not available. Furthermore, reasons for missing
nights were noted. To examine the ability of the bed sensor to
capture sleep-related parameters, the following secondary
outcomes were analyzed: coverage percentages of HR and RR,
distribution of missing HR and RR periods based on duration,
interruptions of HR and RR signals due to bed exits, and the
discrepancy in number of reported and recorded bed exits. The
coverage percentages are the percentages of timestamps in which
HR or RR data were detected by the bed sensor. Because
duration of missing data might have clinical impact, the missing
HR and RR data periods per night were presented in time
categories of <31, 31-60, 61-120, and >120 seconds.
Furthermore, the sensor registers a bed exit if no pressure is
recorded. As a result of getting in or out bed, HR and RR signals
could be interrupted prior to or after a bed exit while the sensor
measures pressure. These adjoining time intervals of missing
HR and RR signals were calculated and referred to as response
time. This response time of HR and RR due to bed exits was
not included in previous outcomes but was investigated
separately. The discrepancy between the number of bed exits
reported by the questionnaire and the number of bed exits
recorded by the bed sensor was described. Average nocturnal
HR was calculated for each night as beats per minute (bpm),
RR as cycles per minute (cpm), and movement activity as AP.
Interference by the researcher if a participant or nurse noticed
and reported an error was noted. In addition, the number of
patients who had to switch rooms and the complaints regarding
the usage of the bed sensor were obtained.
Data and Statistical Analysis
The Emfit company provided bed sensor data in CSV files on
HR, RR, movement activity, and bed exits, based on their
algorithm. A custom MATLAB (R2017b, Version 9.3.0.713579,
The MathWorks Inc) script was used for processing and
analyzing the sleep period data regarding HR, RR, and
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movement activity recorded by the bed sensor. For analysis of
secondary outcomes, measurement nights were only included
if bed sensor data and a complete filled out sleep questionnaire
corresponding to that night were available. The questionnaire
was used to determine the sleep period, time points of sleep
onset, and moments of waking up during each night. Missing
data periods due to bed exits were excluded from the coverage
percentage and missing data calculations. Statistical analyses
were performed with SPSS (version 20.0; IBM Corp) and
RStudio (version 1.2.5042; RStudio, PBC). The level of
statistical significance was set at P<.05. Data were tested for
normality using the Shapiro-Wilk test. A t test was used for
normally distributed data, and a Wilcoxon signed rank test
(paired) or Mann-Whitney U test was used for nonnormally
distributed data. For categorical data, a chi-square test was used.
Descriptive statistics were presented as mean (SD) if data were
normally distributed and as median (range, minimum-maximum)
otherwise. The bed sensor was considered feasible if at least
95% of the nights were covered and the total coverage
percentage of nocturnal HR and RR was above 80% [36]. All
outcome measures were reported for the in-hospital iSCI and
stroke patients separately.
Results
In total, 25 participants (12 iSCI, 13 stroke) were included in
this study. One stroke participant dropped out on the first day
because of the experienced additional cognitive load to
participate in the study. Therefore, data of 24 participants were
analyzed. No statistical differences in sex, age, premorbid sleep
problems, or the use of sleep medication were found between
the iSCI and stroke groups (Table 1).




0.8 (1).397/59/3Gender (male/female), n
N/A.2268.7 (9.0)63.4 (12.9)Age (years), mean (SD)
N/A.0947.0 (25.6)83.8 (67.4)Days since injury, mean (SD)
0 (1)>.9900Premorbid sleep problems, n
0 (1)>.9922Sleep medication, n
iSCI characteristics
N/AN/AN/A1/11ASIAc (AISd C/D), n
N/AN/AN/A7/5SCI level (>T6/<T6), n
N/AN/AN/A4/6/2Lesion level (cervical/thoracic/lumbar), n
Stroke characteristics
N/AN/A7/5N/AStroke location (left/right), n
N/AN/A10/2N/AStroke category (ischemic/hemorrhagic), n
N/AN/A9/1/2N/AStroke type (cortical/subcortical/lacunar), n
aiSCI: incomplete spinal cord injury.
bN/A: not applicable.
cASIA: American Spinal Injury Association.
dAIS: ASIA Impairment Scale.
A total of 67 nights with a median of 5 (range 3-7) per person
for iSCI patients and 65 nights with a median of 5.5 (range 5-7)
per person for stroke patients were measured, adding up to a
total of 132 measurement nights. Of the 132 intended
measurement nights, 5 (3.8%) had missing sensor data (3 iSCI,
2 stroke). The reasons for missing sensor data nights were errors
with the Wi-Fi connection (2), the sensor slipping away from
the bed mattress (1), and unknown reasons (2). Those errors did
not interfere with the sleep of the participants, and the
participants did not report any hindrance from the bed sensor.
Twenty-seven nights were excluded (20.5%) due to incomplete
questionnaires making it impossible to detect the sleep period
(7 iSCI, 20 stroke). One night (0.8%) of a stroke patient could
not be analyzed due to inconsistency regarding end of bedtime
between the sensor data and questionnaire. Therefore, a total
of 99 (57 iSCI, 42 stroke) measurement nights of 20 patients
(11 iSCI, 9 stroke) could be analyzed. The average number of
hours of indicated sleep per night was 8 hours and 1 minute
(SD 1 hour and 7 minutes) for the iSCI group and 8 hours and
10 minutes (SD 33 minutes) for the stroke group (t18=0.3,
P=.74).
Table 2 shows the coverage percentages, mean numbers of
missing data periods per time category, and durations of HR
and RR signal interruptions due to bed exits. For the iSCI group,
coverage percentages of 97% for HR and 93% for RR were
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found. Stroke participants had coverage percentages of 99%
and 97% for HR and RR, respectively. Two-thirds of the missing
HR and RR periods had a short duration of less than 121
seconds. The average duration of bed exits per night was 342
(SD 168) seconds for the iSCI group and 257 (SD 121) seconds
for the stroke group (t16=−1.2, P=.23). The HR response time
(66 seconds; range 0-3972 seconds) to bed exits was
significantly shorter compared to the RR response time (163
seconds; range 0-3226 seconds) (z=−9.0, P<.001). Response
time before bed exits (0 seconds; range 0-3226 seconds) was
significantly shorter than the response time after bed exits (99
seconds; range 0-3972 seconds) (z=−8.4, P<.001).
Table 2. Coverage percentages, mean number of missing data periods per time category (<31, 31-60, 61-120, and >120 s), and response time due to
bed exits of nocturnal HR and RR for iSCI and stroke patients recorded by the bed sensor.
Response time due to bed exits (s), mean (SD)Missing data periods per night, mean (SD)Coverage (%), mean (SD)Group
AfterBefore>120 s61-120 s31-60 s<31 s
iSCIa
141.1 (261.1)9.7 (7.5)1.4 (2.0)1.5 (1.6)1.8 (2.1)3.1 (2.8)96.8 (4.5)HRb
240.8 (294.7)87.1 (100.1)4.6 (2.4)2.3 (0.9)2.1 (1.0)4.6 (1.9)92.5 (4.7)RRc
Stroke
36.2 (25.3)8.4 (8.6)0.5 (0.7)0.7 (0.5)0.8 (0.8)2.0 (1.2)99.3 (0.6)HR
103.1 (46.5)61.8 (78.9)2.4 (2.0)1.6 (1.6)2.0 (1.5)3.1 (1.7)96.7 (2.6)RR
aiSCI: incomplete spinal cord injury.
bHR: heart rate.
cRR: respiratory rate.
Patients with iSCI reported a total of 86 bed exits by
questionnaire, of which 84 were recorded by the bed sensor.
Stroke patients reported a total of 42 bed exits, whereas 57 bed
exits were recorded. There was a difference between
self-reported and recorded bed exits per night in 15 of the 57
nights (26%) for iSCI and in 16 of the 42 nights (38%) for stroke
patients (Table 3).
Table 3. Difference in reported and recorded bed exits per night for iSCI and stroke patients.




aNegative value indicates fewer reported bed exits; positive value indicates more reported bed exits.
biSCI: incomplete spinal cord injury.
The nocturnal HR in iSCI (72 bpm, SD 13 bpm) was
significantly higher compared to the stroke group (61 bpm, SD
8 bpm; t18=−2.1, P=.04). Nocturnal RR was 16 (SD 3) cpm and
15 (SD 1) cpm for iSCI and stroke, respectively (t18=−2.4,
P=.21). Average nocturnal movement activity was significantly
different between iSCI (239 AP, SD 116 AP) and stroke (136
AP, 49 AP) (t18=−1.2, P=.02). The median percentage for
movement activity of large movements (>500 AP) was
significantly larger in iSCI patients (5.7%, range 1.8%-28.2%)
compared to stroke patients (2.8%, range 0.4%-4.9%) (z=2.2,
P=.03). Furthermore, no errors were noted, no participants had
to switch rooms, and none of the participants had any complaints
regarding the usage of the bed sensor.
Discussion
The aim of this study was to investigate the feasibility of an
unobtrusive, contactless, portable bed sensor for continuous
sleep monitoring overnight in a clinical rehabilitation SCI and
stroke ward. Sensor data were available for more than 95% of
the measured nights. The bed sensor was able to capture HR
and RR with high coverage percentages between 92% and 99%,
with only short missing HR and RR periods during the night
and some interruptions of the HR and RR signals caused by bed
exits. iSCI patients had significantly higher nocturnal HR and
movement activity than stroke patients. Moreover, no complaints
were mentioned regarding the use of the bed sensor. These
findings indicate the feasibility of an unobtrusive, contactless,
portable bed sensor for continuous sleep monitoring overnight
within a clinical setting.
The 3.8% (5/132) missing measurement nights fell within the
5% boundary for feasibility and are in line with literature
regarding missing data of various sensor technologies
[36,43,44]. Another important positive finding of this study was
the high coverage rates (>92%) of HR and RR in both patient
groups. These coverage percentages largely exceeded the set
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boundary of 80% and are at the upper limit of what has been
found in literature; studies found average coverage percentages
of 83% [26] and 93% [27] for HR and 87% [26] for RR using
unobtrusive, contactless, portable sensors under bed mattresses
at home and in sleep centers. A possible explanation for our
slightly higher coverage percentages might be the exclusion of
bed exits and response time due to bed exits. However, patients
are not asleep around bed exits, which causes those periods to
be clinically less relevant for HR and RR signals. Furthermore,
the missing data due to bed exits were mostly short periods of
signal interruptions (<31 seconds). Including bed exits in the
coverage percentages would reduce the coverage by less than
3%: iSCI HR 94.6% (SD 5.0) and RR 89.6% (SD 6.0), stroke
HR 97.9% (SD 1.3) and RR 95.0% (SD 3.0)). Therefore, the
clinically relevant nocturnal HR and RR signals could almost
entirely be monitored with the bed sensor.
A high coverage of HR and RR is essential to assess HR- and
RR-based functional sleep outcomes. Possible interesting HR-
and RR-based functional outcomes for clinicians from the bed
sensor could be (1) time in bed, (2) sleep latency, (3) sleep
efficiency, (4) total time awake, (5) total sleep time, (6) sleep
stages (%), and (7) apnea-hypopnea index [1,12,32,45,46]. To
determine these functional sleep outcomes, it is important that
HR and RR, as well as movement, can properly be measured
with the bed sensor. So far, the bed sensor has appeared to be
suitable for measurement of HR and RR in laboratory studies
with healthy subjects [47-49]. Previous studies found
significantly higher HR in low paraplegia SCI patients compared
to healthy controls [37] and similar HR in stroke patients and
healthy controls [38]. The higher HR in iSCI compared to stroke
patients in this study supports higher nocturnal HR in iSCI
patients. Although nocturnal RR data in SCI and stroke patients
in literature is lacking, nocturnal RR was within the range of a
normal population [50]. Studies reporting on nocturnal
movement activity are scarce. Based on this study, iSCI patients
seem to have a significantly higher percentage of large body
movements compared to stroke patients. The abovementioned
findings support the bed sensor's ability to discriminate between
different groups and is a first indication toward group validity.
It suggests that HR, RR, and nocturnal movement activity can
be monitored by bed sensors on the rehabilitation ward, but this
needs further study and comparison with healthy controls.
Despite the wide range of sleep technology devices, the perfect
sleep assessment method does not yet exist: all methods have
their advantages and disadvantages [14]. Disadvantages of the
portable bed sensor are that the sensor cannot be used in
combination with an airflow mattress and that it is designed for
sleep detection with intention to sleep. However, in-hospital
patients are often inactive due to physical impairments and
therefore spend a lot of time in their bed without the intention
to sleep, which the sensor cannot distinguish from being asleep.
Hence, further validation of the portable bed sensor is needed,
and attention must be paid to the overestimation of sleep time,
sleep onset, and wake/sleep periods in a greater proportion of
the rehabilitation center population [20,46,51].
A limitation of our study was that the data analysis was
dependent on completely filled out sleep questionnaires. During
our study, we were confronted with a disadvantage of using
sleep questionnaires that has been reported previously [14,20].
Patients, especially stroke patients with mild cognitive
impairment, did not fill them out regularly and accurately, which
was supported by the difference in reported and recorded bed
exits. As a consequence, a large proportion (27/132, 20.5%) of
measurement nights could not be used in data analysis. In
contrast, only 3.8% (5) of the nights were missing due to
technical errors. Nonetheless, subjective sleep measures assess
more habitual patterns of sleep and sleepiness compared to the
objective monitoring of different body functions during sleep
[14,16]. Therefore, combining subjective and objective measures
of sleep may provide a more comprehensive, continuous
evaluation of sleep quality. The bed sensor is a more robust way
of sleep monitoring and can complement the subjective sleep
assessment in the clinical setting. Therefore, future research
should study more extensively the validity of the unobtrusive,
contactless, portable bed sensor in immobilized patients within
rehabilitation populations, in comparison with healthy controls.
In conclusion, the unobtrusive, contactless, portable bed sensor
is a promising and feasible instrument to monitor sleep in the
clinical rehabilitation setting. This provides a good foundation
for further development of these types of sensors targeting sleep
types and sleep disorders.
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